相关实验视频
Updated: Jul 20, 2025

07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
85.0K
间歇性缺氧通过HIF-1和miRNA调节促进癌症的发展和进展
Giorgia Moriondo1, Piera Soccio1, Mélanie Minoves2
1Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
Archivos de bronconeumologia
|July 30, 2023
概括
阻塞性睡眠呼吸暂停 (OSA) 通过缺氧诱导的microRNAs (miRNAs) 与癌症有关. 在结直肠癌细胞中间歇性缺氧 (IH) 促进了增长和迁移,由特定的miRNA和HIF-1信号传递介导.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 睡眠医学 睡眠医学
背景情况:
- 阻塞性睡眠呼吸暂停 (OSA) 和癌症之间的关系仍在争论中,基础机制尚不清楚.
- 低氧是OSA的常见特征,影响微RNA (miRNA) 表达,这对癌症的发展和进展起着作用.
研究的目的:
- 为了比较对照组,OSA患者和患有OSA (ONCO-OSA) 的癌症患者的miRNA表达.
- 在实验室中研究间歇性缺氧 (IH) 对结直肠癌细胞进展的影响.
主要方法:
- 定量逆转录PCR (qRT-PCR) 检测患者血清和CaCo2细胞中的miRNAs.
- 细胞活力和通井入侵测试,以评估增殖和迁移.
- 抑制HIF-1α和特定的miRNAs,以评估它们在IH诱导影响中的作用.
主要成果:
- 在OSA和/或ONCO-OSA患者和暴露于IH的CaCo2细胞中,特定的miRNAs (miR-21,miR-26a,miR-210,miR-23b) 被上调.
- IH显著增加了结直肠癌细胞的增殖和迁移.
- 这些miRNA或HIF-1α活动的抑制减弱了IH诱导的增殖和迁移.
结论:
- 通过IH环境诱导的独特miRNA签名被确定.
- 这些miRNAs可能会通过涉及HIF-1的调节循环促进癌症的发展和进展.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Hypoxia
1.1K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
1.1K

